INTRODUCTION
Hepatitis B virus (HBV) is a small, enveloped, partially double-stranded DNA virus that belongs to the Hepadnaviridae family. HBV is a disease of global concern that caused 1.34 million deaths in 2015, a number comparable to death caused by tuberculosis and higher than those caused by HBV (WHO Global Hepatitis Report, 2017). The number of deaths due to viral hepatitis is increasing over time. Currently, the available antiviral drugs include interferon-alpha (IFN-α) and nucleotide analogue inhibitors of HBV polymerase, among which lamivudine (3TC), telbivudine (LdT), entecavir (ETV), adefovir (ADV) and tenofovir (TDV) have been approved by the FDA (Figure 1 ). 1 HBV DNA polymerase (HDP) is interested object for treatment of HBV infections in the last few years. There are seven agents are approved for the treatment of chronic HBV. There are two biological products which have shown very good anti-HBV activity such as Interferon alfa-2b (IFN) and long-acting pegylated interferon (peginterferon) alfa-2a (PEG-IFN). However, there are some troubles for that product such as practicality, high cost, effectiveness for the treatment of chronic HBV. There are some publication that studied lead compound for inhibiting the replication of the viral core protein such as a QSAR study on bis (L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine of anti-HBV agent. 1 Cannabinoid that found in cannabisplant was effective for HBV-virus treatment. 2 Virtual screening of Cocculus hirsutus compounds has been studied for anti-HBV by Samuel Thavamani et al. 3 that used GLID software. [4] [5] [6] Cluster Analysis and QSAR Study of Some Anti-hepatitis B Virus Agents Comprising 4-Aryl-6-chloro-quinolin-2-ones and 5-Aryl-7-chloro-1, 4-benzodiazepines. 7 Sheng Liu et al. created the docking and synthesis design of phenylpropanoid derivatives for anti -HBV. 8 Recently, a computational study is the best choice to reduce a cost and time for searching a lead compound. In this article, we report a computational study to predict the IC 50 value and molecular dynamic simulation that can be verified the stability of the best compound for a lead compound to HBV.
MATERIALS AND METHODS
For the present study, the crystal structure of HBV capsid (PDB code 5E0I) were downloaded from the protein data bank (http://www.rcsb. org).9 A set of standard ligands ( Table 1 ) that inhibit the replication of the viral core protein were taken from the literature. 10 The ligands docked onto the active site of HBV core protein using Autodock 4.2,11 Autodock vina12 and Plats program. 13 The best ligand result that be continued to molecular dynamic simulation by Amber 14.14
Selection of Standard Compounds
The compounds were selected from the literature. 10 The docking set consist derivates of bis (L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl] adenine (PMEA), Lamivudine and Adefovir dipivoxil with IC 50 value. To validate the simulation model, that compounds ware used as a test set (see Table 1 ). The IC 50 values in units of mM were transformed in pIC 50 (logIC 50 ) to give numerically more significant data.
Docking Studies
The 2D structures of ligand (standard and samples) were drawn by 
Statistic analysis
In the present study, five parameters (such as docking score, molecular weight, log P, Polarizability, Polar Surface (2D) and Molecular Surface (3D) of each compound simulation were evaluated using statistic program for getting the equation.
Molecular Dynamic Simulation
The simulation was carried out using the Amber 14 Molecular Dynamics package. 9 The system, prepared as solvated complex by carrying out a
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RESULT
Docking studies have been done on the compound structure of standard which is already successfully synthesized and known its activity as anti-HBV (see Table 1 ).
DISCUSSION

Docking Studies
Docking studies have been done on the compound structure of standard which is already successfully synthesized and known its activity as anti-HBV that will be a standard ligand for docking simulation on 5E0I using Autodock 4.2, Autodock vina and Plant. We will obtain docking score information (the lowest energy of ligand pose) and physic properties (Table 2) . Statistical analysis has been done using a multivariate method and is obtained an equation that will be used to predict IC 50 of the compound in Curcuma (Eq 1, 2 and 3) .
CONCLUSION
In conclusion, these computational studies not only shed light on understanding the IC 50 prediction of the replication of the viral core protein inhibition, but also the stability of each interaction that inhibits of the viral core protein replication.
pIC50 prediction = 1.061 -0.220 Docking Score -0. 
Molecular Dynamic Simulation
The relative stability of the whole model can be measured as the root mean square deviation (RMSD) of backbone atoms from the initial structure as a function of time. The model built with the ptraj program in the Amber 14 package was taken as the initial structure for comparison. The RMSD in Figure 2 was calculated for each MD snapshot (one every 10 ps) after the coordinates of the model were superimposed on the coordinates of the initial structure. The backbone RMSD values of the two systems tend to be convergent after 2 ns of simulation, with fluctuations of 4.5 Å and 4 Å approximately for the structures of the viral core protein. It means the system of molecular dynamic was stable during the simulation interaction. The structures from before and after MD simulation are shown in Figure 3 . Docking into the protein structure obtained after 20 ns of MD simulation produced smaller binding energy interaction poses than before MD simulation. The docking score that got after MD simulation shown at Table 5 . The Total energy of 2, 3, 5-trihydroxybenzoic acid after MD simulation was lower than before MD simulation, it means the structure of 2,3,5-trihydroxybenzoic acid was stable during simulation that can inhibit viral core protein replication. 
